Pd-L1 Overexpression In Solid Tumours In 18 Major Markets | Forecast Report 2017-2027
(EMAILWIRE.COM, January 30, 2018 ) PD-1 is a T-cell immune checkpoint that is involved in the dampening of autoimmunity in the peripheral effector phase of T-cell activation. This leads to a tolerance of cells expressing PD-L1 (programmed death ligand-1). PD-L1 is expressed normally on a number...
Subscribe to Applenews247.Com Newsletter